Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMSW
- CUSIP Number: n62509117
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Frazier Life Sciences Management | 500k | $1.6M | 0% | Dec 2023 |
|
RA Capital Management | 333k | $1.0M | 0% | Dec 2023 |
|
Deerfield Management Company | 93k | $290k | 0% | Dec 2023 |
|
ADAR1 Capital Management | 83k | $259k | 100% | Dec 2023 |
|
Millennium Management | 75k | $235k | 0% | Dec 2023 |
|
EcoR1 Capital | 67k | $745k | 0% | Dec 2023 |
|
Westchester Capital Management | 31k | $98k | 0% | Dec 2023 |
|
Hrt Financial | 30k | $94k | 0% | Dec 2023 |
|
Walleye Trading Advisors | 23k | $71k | 0% | Dec 2023 |
|
Laurion Capital Management | 17k | $52k | 0% | Dec 2023 |
|
Walleye Trading | 13k | $41k | 0% | Dec 2023 |
|
Who sold out of Newamsterdam Pharma Co Nv?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Highbridge Capital Management | Sep 2023 | 54k | $92k |